Literature DB >> 10799431

Angiotensin for septic shock unresponsive to noradrenaline.

M Yunge1, A Petros.   

Abstract

Two children with severe septic shock are reported. One had meningococcal septicaemia and the other Escherichia coli septicaemia. They remained hypotensive despite high concentrations of conventional inotropes and vasopressors. In one child, using a pulmonary artery catheter, extended haemodynamic variables were measured. To restore blood pressure, in both cases, an infusion of angiotensin II was used; there was significant improvement in clinical status, resulting in a rapid reduction in the concentration of inotropes required. Both patients successfully survived their septic episodes. Angiotensin II in cases of severe refractory septic hypotension in the paediatric population offers an extra therapeutic manoeuvre.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10799431      PMCID: PMC1718307          DOI: 10.1136/adc.82.5.388

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  4 in total

1.  Extracorporeal support for intractable cardiorespiratory failure due to meningococcal disease.

Authors:  A P Goldman; S J Kerr; W Butt; M J Marsh; I A Murdoch; T Paul; R K Firmin; R C Tasker; D J Macrae
Journal:  Lancet       Date:  1997-02-15       Impact factor: 79.321

2.  Severe septic shock unresponsive to noradrenaline.

Authors:  G M Wray; J H Coakley
Journal:  Lancet       Date:  1995-12-16       Impact factor: 79.321

3.  Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway.

Authors:  G Julou-Schaeffer; G A Gray; I Fleming; C Schott; J R Parratt; J C Stoclet
Journal:  Am J Physiol       Date:  1990-10

4.  Angiotensin II, vasopressin, and sympathetic activity in conscious rats with endotoxemia.

Authors:  M D Schaller; B Waeber; J Nussberger; H R Brunner
Journal:  Am J Physiol       Date:  1985-12
  4 in total
  11 in total

1.  Distinct effects of intravascular and extravascular angiotensin II on cerebrovascular circulation of newborn pigs.

Authors:  Kenneth R Knecht; Charles W Leffler
Journal:  Exp Biol Med (Maywood)       Date:  2010-12

Review 2.  Recent advances in sepsis and septic shock.

Authors:  Praveen Khilnani; Satish Deopujari; Joe Carcillo
Journal:  Indian J Pediatr       Date:  2008-09-04       Impact factor: 1.967

3.  Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine.

Authors:  Joe Brierley; Joseph A Carcillo; Karen Choong; Tim Cornell; Allan Decaen; Andreas Deymann; Allan Doctor; Alan Davis; John Duff; Marc-Andre Dugas; Alan Duncan; Barry Evans; Jonathan Feldman; Kathryn Felmet; Gene Fisher; Lorry Frankel; Howard Jeffries; Bruce Greenwald; Juan Gutierrez; Mark Hall; Yong Y Han; James Hanson; Jan Hazelzet; Lynn Hernan; Jane Kiff; Niranjan Kissoon; Alexander Kon; Jose Irazuzta; Jose Irazusta; John Lin; Angie Lorts; Michelle Mariscalco; Renuka Mehta; Simon Nadel; Trung Nguyen; Carol Nicholson; Mark Peters; Regina Okhuysen-Cawley; Tom Poulton; Monica Relves; Agustin Rodriguez; Ranna Rozenfeld; Eduardo Schnitzler; Tom Shanley; Saraswati Kache; Sara Skache; Peter Skippen; Adalberto Torres; Bettina von Dessauer; Jacki Weingarten; Timothy Yeh; Arno Zaritsky; Bonnie Stojadinovic; Jerry Zimmerman; Aaron Zuckerberg
Journal:  Crit Care Med       Date:  2009-02       Impact factor: 7.598

Review 4.  Angiotensin II in septic shock.

Authors:  Thiago D Corrêa; Jukka Takala; Stephan M Jakob
Journal:  Crit Care       Date:  2015-03-16       Impact factor: 9.097

Review 5.  The effect of angiotensin II on blood pressure in patients with circulatory shock: a structured review of the literature.

Authors:  Laurence W Busse; Michael T McCurdy; Osman Ali; Anna Hall; Huaizhen Chen; Marlies Ostermann
Journal:  Crit Care       Date:  2017-12-28       Impact factor: 9.097

Review 6.  Clinical Experience With IV Angiotensin II Administration: A Systematic Review of Safety.

Authors:  Laurence W Busse; Xueyuan Shelly Wang; Divya M Chalikonda; Kevin W Finkel; Ashish K Khanna; Harold M Szerlip; David Yoo; Sharon L Dana; Lakhmir S Chawla
Journal:  Crit Care Med       Date:  2017-08       Impact factor: 7.598

7.  Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin II.

Authors:  James A Tumlin; Raghavan Murugan; Adam M Deane; Marlies Ostermann; Laurence W Busse; Kealy R Ham; Kianoush Kashani; Harold M Szerlip; John R Prowle; Azra Bihorac; Kevin W Finkel; Alexander Zarbock; Lui G Forni; Shannan J Lynch; Jeff Jensen; Stew Kroll; Lakhmir S Chawla; George F Tidmarsh; Rinaldo Bellomo
Journal:  Crit Care Med       Date:  2018-06       Impact factor: 7.598

8.  Angiotensin II in experimental hyperdynamic sepsis.

Authors:  Li Wan; Christoph Langenberg; Rinaldo Bellomo; Clive N May
Journal:  Crit Care       Date:  2009-11-30       Impact factor: 9.097

9.  Severe sepsis: Low expression of the renin-angiotensin system is associated with poor prognosis.

Authors:  Wei Zhang; Xiaowei Chen; Ling Huang; Ning Lu; Lei Zhou; Guojie Wu; Yuguo Chen
Journal:  Exp Ther Med       Date:  2014-02-20       Impact factor: 2.447

10.  Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study.

Authors:  Lakhmir S Chawla; Laurence Busse; Ermira Brasha-Mitchell; Danielle Davison; Jacqueline Honiq; Ziyad Alotaibi; Michael G Seneff
Journal:  Crit Care       Date:  2014-10-06       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.